Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...